CSIMarket Company Name, Ticker, Customers, else..
 
Spruce Biosciences Inc   (NASDAQ: SPRB)
 

Spruce Biosciences Inc's Suppliers Performance

SPRB's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
SPRB Costs vs Sales of Suppliers Growth

• More on SPRB Suppliers






Spruce Biosciences Inc's Comment on Supply Chain


The company maintains manufacturing, development, and supply agreements with contract manufacturing organizations (CMOs) for the procurement of active pharmaceutical ingredients (API) and drug products to support clinical trials and commercial requirements of TA-ERT. These CMOs have met manufacturing standards to date and are expected to supply sufficient quantities for full-scale commercial production. Internal personnel with pharmaceutical development and manufacturing experience oversee these relationships. The contract manufacturing agreements offer visibility into future production costs, and the company anticipates that the cost of goods for TA-ERT will be competitive relative to currently marketed orphan disease therapies.

Spruce Biosciences Inc's Comment on Supply Chain


The company maintains manufacturing, development, and supply agreements with contract manufacturing organizations (CMOs) for the procurement of active pharmaceutical ingredients (API) and drug products to support clinical trials and commercial requirements of TA-ERT. These CMOs have met manufacturing standards to date and are expected to supply sufficient quantities for full-scale commercial production. Internal personnel with pharmaceutical development and manufacturing experience oversee these relationships. The contract manufacturing agreements offer visibility into future production costs, and the company anticipates that the cost of goods for TA-ERT will be competitive relative to currently marketed orphan disease therapies.







SPRB's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Spruce Biosciences Inc 120.13 0.00 -51.35 8
SUBTOTAL 0.00 0.00 0.00 -


Sources: Spruce Biosciences Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Spruce Biosciences Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.